Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 2, 2004, Pages 591-596

  Chang, Sung Hee ^a   Liu, Catherine H ^a   Conway, Rebecca ^a   Han, David K ^a   Nithipatikom, Kasem ^b   Trifan, Ovidiu C ^c   Lane, Timothy F ^d   Hla, Timothy ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mammary cancer; Prostaglandin E2 receptors; Tumor angiogenesis

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; G PROTEIN COUPLED RECEPTOR; INDOMETACIN; PROSTAGLANDIN E2; PROSTANOID; ISOENZYME; PROSTAGLANDIN SYNTHASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; MAMMARY GLAND; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE; TUMOR GROWTH; UPREGULATION; ANIMAL; DISEASE COURSE; ELECTROSPRAY MASS SPECTROMETRY; EXPERIMENTAL NEOPLASM; LIQUID CHROMATOGRAPHY; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALIA; MUS MUSCULUS;

ANIMALS; CHROMATOGRAPHY, LIQUID; CYCLOOXYGENASE 2; DINOPROSTONE; DISEASE PROGRESSION; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0347717578     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.2535911100     Document Type: Article

References (35)

1. Smith, W. L., DeWitt, D. L. & Garavito, R. M. (2000) Annu. Rev. Biochem. 69, 145-182.
2. Hla, T., Bishop-Bailey, D., Liu, C. H., Schaefers, H. J. & Trifan, O. C. (1999) Int. J. Biochem. Cell Biol. 31, 551-557.
3. Thun, M. J. (1996) Gastroenterol. Clin. North Am. 25, 333-348.
4. Gupta, R. A. & Dubois, R. N. (2001) Nat. Rev. Cancer 1, 11-21.
5. Taketo, M. M. (1998) J. Natl. Cancer Inst. 90, 1529-1536.
6. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. & Reddy, B. S. (1995) Cancer Res. 55, 1464-1472.
7. Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J. & Seibert, K. (2000) Cancer Res. 60, 1306-1311.
8. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F. & Taketo, M. M. (1996) Cell 87, 803-809.
9. Ristimaki, A., Sivula, A., Lundin, J., Lundin, M., Salminen, T., Haglund, C., Joensuu, H. & Isola, J. (2002) Cancer Res. 62, 632-635.
10. Harris, R. E., Namboodiri, K. K. & Farrar, W. B. (1996) Epidemiology 7, 203-205.
11. Harris, R. E., Alshafie, G. A., Abou-Issa, H. & Seibert, K. (2000) Cancer Res. 60, 2101-2103.
12. Howe, L. R., Subbaramaiah, K., Patel, J., Masferrer, J. L., Deora, A., Hudis, C., Thaler, H. T., Muller, W. J., Du, B., Brown, A. M., et al. (2002) Cancer Res. 62, 5405-5407.
13. Richards, J. A. & Brueggemeier, R. W. (2003) J. Clin. Endocrinol. Metab. 88, 2810-2816.
14. Liu, C. H., Chang, S. H., Narko, K., Trifan, O. C., Wu, M. T., Smith, E., Haudenschild, C., Lane, T. F. & Hla, T. (2001) J. Biol. Chem. 276, 18563-18569.
15. Muller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F. & Furstenberger, G. (2002) Proc. Natl. Acad. Sci. USA 99, 12483-12488.
16. Silver, R. M., Edwin, S. S., Trautman, M. S., Simmons, D. L., Branch, D. W., Dudley, D. J. & Mitchell, M. D. (1995) J. Clin. Invest. 95, 725-731.
17. Peebles, R. S., Jr., Hashimoto, K., Morrow, J. D., Dworski, R., Collins, R. D., Hashimoto, Y., Christman, J. W., Kang, K. H., Jarzecka, K., Furlong, J., et al. (2002) Am. J. Respir. Crit. Care Med. 165, 1154-1160.
18. Thurston, G., Baluk, P., Hirata, A. & McDonald, D. M. (1996) Am. J. Physiol. 271, H2547-H2562.
19. Hovey, R. C., Goldhar, A. S., Baffi, J. & Vonderhaar, B. K. (2001) Mol. Endocrinol. 15, 819-831.
20. Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C. X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S. S., Lee, M. J., et al. (2000) J. Clin. Invest. 106, 951-961.
21. Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., et al. (2000) Oncogene 19, 968-988.
22. Nithipatikom, K., Laabs, N. D., Isbell, M. A. & Campbell, W. B. (2003) J. Chromatogr. B 785, 135-145.
23. Brem, S. S., Gullino, P. M. & Medina, D. (1977) Science 195, 880-882.
24. Heffelfinger, S. C., Miller, M. A., Yassin, R. & Gear, R. (1999) Clin. Cancer Res. 5, 2867-2876.
25. Lazard, D., Sastre, X., Frid, M. G., Glukhova, M. A., Thiery, J. P. & Koteliansky, V. E. (1993) Proc. Natl. Acad. Sci. USA 90, 999-1003.
26. Lala, P. K., Al-Mutter, N. & Orucevic, A. (1997) Int. J. Cancer 73, 371-380.
27. Ben-Av, P., Crofford, L. J., Wilder, R. L. & Hla, T. (1995) FEBS Lett. 372, 83-87.
28. Seno, H., Oshima, M., Ishikawa, T. O., Oshima, H., Takaku, K., Chiba, T., Narumiya, S. & Taketo, M. M. (2002) Cancer Res. 62, 506-511.
29. Hanahan, D. & Folkman, J. (1996) Cell 86, 353-364.
30. Gimbrone, M. A., Jr., & Gullino, P. M. (1976) Cancer Res. 36, 2611-2620.
31. Dvorak, H. F. (2003) Am. J. Pathol. 162, 1747-1757.
32. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J. & Holash, J. (2000) Nature 407, 242-248.
33. Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K. & McDonald, D. M. (2002) Am. J. Pathol. 160, 985-1000.
34. Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M. & Taketo, M. M. (2001) Nat. Med. 7, 1048-1051.
35. Sheng, H., Shao, J., Washington, M. K. & DuBois, R. N. (2001) J. Biol. Chem. 276, 18075-18081.